← Home / LISATA THERAPEUTICS, INC. (LSTA)
Stock Analysis
LISATA THERAPEUTICS, INC. (LSTA)
LSTA
LSTA · Market data
3.27 +0.93%
52W Range Position
44%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-12 19:55 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 3.33. Holding above 3.26 keeps the current thesis intact.
⚖️
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
3.26
↗
Break Above
Confirmation improves above resistance.
3.33
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 3.26
What's Driving LSTA?
📈 Technical recovery is improving
Momentum is Neutral. Watch 3.33 for confirmation and 3.26 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 3.26
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
42.2
◎
How to read this setup
The nearest decision zone is framed by support around 1.81 and resistance near 3.37. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control.
Price Chart
LSTA · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-10
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$29.8M
Company size
EV
$21.6M
Debt-adjusted value
P/E
-2.0
Not meaningful
P/S
124.1
Very high
P/B
2.8
Balanced
EV/Sales
90.1
Very high
EV/EBIT
-1.4
Not meaningful
P/FCF
-1.9
Not meaningful
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
≈
Cash Flow
Recovering
⚖
Balance Sheet
Strong
💵 Revenue
0.00
≈ Insufficient
📈 Net Income
-4.49M
≈ Insufficient
🧮 EPS (Basic)
-0.50
≈ Insufficient
LISATA THERAPEUTICS, INC.
Related Opportunities